Allergan Gets Shire's Dry-Eye Drug Antitrust Suit Dropped
A New Jersey federal judge has dismissed Shire's suit accusing Allergan of having a "stranglehold" on the Medicare market for dry-eye drugs after finding that the pharmaceutical company failed to prove...To view the full article, register now.
Already a subscriber? Click here to view full article